bisoprolol has been researched along with Hypertension, Pulmonary in 3 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In experimental PH, treatment with bisoprolol delays progression toward right heart failure, and partially preserves RV systolic and diastolic function." | 7.78 | Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. ( Bogaards, SJ; de Man, FS; Handoko, ML; Paulus, WJ; Postmus, PE; Schalij, I; van Ballegoij, JJ; van der Velden, J; Vonk-Noordegraaf, A; Westerhof, N, 2012) |
| "To study effects of a selective beta1-adrenoblocker (B1AB) bisoprolol fumarate (conkor, Nikomed, Germany) on severity of pulmonary hypertension (PH), bronchial obstruction and bioelectric activity of the myocardium in patients with chronic obstructive pulmonary disease (COPD) associated with ischemic heart disease (IHD)." | 5.12 | [Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease]. ( Tsvetkova, OA; Veselovskaia, MV, 2007) |
| "In experimental PH, treatment with bisoprolol delays progression toward right heart failure, and partially preserves RV systolic and diastolic function." | 3.78 | Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. ( Bogaards, SJ; de Man, FS; Handoko, ML; Paulus, WJ; Postmus, PE; Schalij, I; van Ballegoij, JJ; van der Velden, J; Vonk-Noordegraaf, A; Westerhof, N, 2012) |
| " We investigated pulmonary protein and amino acid metabolism, the biochemical basis of the remodeling process, in individuals with chronic heart failure receiving or not receiving β-blocker therapy with bisoprolol (BIS)." | 3.78 | Lung anabolic activity in patients with chronic heart failure: potential implications for clinical practice. ( Aquilani, R; Baiardi, P; Bongiorno, AI; Boschi, F; Dossena, M; Febo, O; Iadarola, P; La Rovere, MT; Pastoris, O; Verri, M; Viglio, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Man, FS | 1 |
| Handoko, ML | 1 |
| van Ballegoij, JJ | 1 |
| Schalij, I | 1 |
| Bogaards, SJ | 1 |
| Postmus, PE | 1 |
| van der Velden, J | 1 |
| Westerhof, N | 1 |
| Paulus, WJ | 1 |
| Vonk-Noordegraaf, A | 1 |
| Aquilani, R | 1 |
| La Rovere, MT | 1 |
| Febo, O | 1 |
| Baiardi, P | 1 |
| Boschi, F | 1 |
| Iadarola, P | 1 |
| Viglio, S | 1 |
| Dossena, M | 1 |
| Bongiorno, AI | 1 |
| Pastoris, O | 1 |
| Verri, M | 1 |
| Tsvetkova, OA | 1 |
| Veselovskaia, MV | 1 |
1 trial available for bisoprolol and Hypertension, Pulmonary
| Article | Year |
|---|---|
[Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Blood Gas Analysis; Female; Heart Conduction System; Humans | 2007 |
2 other studies available for bisoprolol and Hypertension, Pulmonary
| Article | Year |
|---|---|
Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Antihypertensive Agents; Bisoprolol; Disease Models | 2012 |
Lung anabolic activity in patients with chronic heart failure: potential implications for clinical practice.
Topics: Adrenergic beta-1 Receptor Antagonists; Airway Remodeling; Amino Acids; Arteries; Bisoprolol; Chroni | 2012 |